OssDsign Toekomstige groei

Future criteriumcontroles 2/6

OssDsign zal naar verwachting groeien in winst en omzet met respectievelijk 55.9% en 23.9% per jaar. De winst per aandeel zal naar verwachting groeien met 58.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -20.7% zijn.

Belangrijke informatie

55.9%

Groei van de winst

58.5%

Groei van de winst per aandeel

Medical Equipment winstgroei	33.0%
Inkomstengroei	23.9%
Toekomstig rendement op eigen vermogen	-20.7%
Dekking van analisten	Low
Laatst bijgewerkt	23 Oct 2024

Recente toekomstige groei-updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 23

Recent updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 23

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Aug 06

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

Jun 19

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

Mar 19

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Aug 19

Winst- en omzetgroeiprognoses

OM:OSSD - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SEK Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	217	-25	-28	-27	3
12/31/2025	169	-42	-43	-42	4
12/31/2024	124	-56	-76	-75	4
6/30/2024	123	-114	-91	-91	N/A
3/31/2024	118	-118	-95	-95	N/A
12/31/2023	112	-130	-94	-94	N/A
9/30/2023	97	-109	-93	-93	N/A
6/30/2023	83	-95	-93	-93	N/A
3/31/2023	71	-99	-92	-92	N/A
12/31/2022	57	-99	-86	-86	N/A
9/30/2022	46	-96	-82	-82	N/A
6/30/2022	38	-93	-98	-98	N/A
3/31/2022	33	-95	-90	-90	N/A
12/31/2021	32	-94	-90	-90	N/A
9/30/2021	29	-90	-94	-93	N/A
6/30/2021	27	-92	-77	-76	N/A
3/31/2021	23	-90	-83	-80	N/A
12/31/2020	25	-85	-82	-79	N/A
9/30/2020	24	-89	-81	-79	N/A
6/30/2020	22	-89	-90	-88	N/A
3/31/2020	22	-85	-87	-86	N/A
12/31/2019	18	-84	-87	-87	N/A
9/30/2019	18	-72	-92	-90	N/A
6/30/2019	20	-66	-79	-75	N/A
3/31/2019	21	-62	-83	-78	N/A
12/31/2018	21	-56	-74	-66	N/A
12/31/2017	16	-63	N/A	-41	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat OSSD de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat OSSD de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat OSSD de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van OSSD ( 23.9% per jaar) zal naar verwachting sneller groeien dan de markt Swedish ( 0.03% per jaar).

Hoge groei-inkomsten: De omzet van OSSD ( 23.9% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Er wordt voorspeld dat OSSD binnen 3 jaar verliesgevend zal zijn.

OssDsign Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

No longer forecast to breakeven

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 30%, revenue upgraded

Forecast breakeven date moved forward to 2024

Ossdsign AB (Publ) Provides Revenue Guidance for the Fourth Quarter of 2023

Recent updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Second quarter 2024 earnings: EPS misses analyst expectations

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

OssDsign AB (publ) Approves Election of Christer Fåhraeus as Ordinary Board Member

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on Jun 04, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on May 22, 2024

No longer forecast to breakeven

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer

New minor risk - Share price stability

Forecast breakeven date moved forward to 2024

OssDsign AB (publ), Annual General Meeting, May 21, 2024

Consensus EPS estimates fall by 30%, revenue upgraded

Forecast breakeven date moved forward to 2024

OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion

OssDsign AB (publ) to Report Q3, 2024 Results on Nov 05, 2024

OssDsign AB (publ) Reports Exceptional Data from the Clinical Study TOP FUSION

Ossdsign AB (Publ) Provides Revenue Guidance for the Fourth Quarter of 2023

An Unknown buyer acquired 7.6% stake in OssDsign AB (publ) (OM:OSSD).

OssDsign AB (publ) to Report Fiscal Year 2023 Results on Feb 06, 2024

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 150.000003 million.

OssDsign AB (publ) Announces All Activities Pertaining to the Patient-Specific Cranial Implant Business Will Be Discontinued in A Responsible Manner by the End of December 2023

OssDsign Receives FDA Clearance for A New Major Indication

Consensus EPS estimates fall by 15%

Consensus estimates of losses per share improve by 14%

Second quarter 2023 earnings released: kr0.30 loss per share (vs kr0.40 loss in 2Q 2022)

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Forecast breakeven date moved forward to 2024

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

No longer forecast to breakeven

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Full year 2022 earnings released: kr1.70 loss per share (vs kr1.94 loss in FY 2021)

OssDsign AB (publ) to Report Fiscal Year 2022 Results on Feb 21, 2023

Forecast to breakeven in 2025

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 65.63568 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

OssDsign AB (publ) Ordinary Shares to Be Deleted from OTC Equity

High number of new directors

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

OssDsign AB (publ) Elects Jill Shiaparelli as Board Member

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to kr14.00

Insufficient new directors

Consensus revenue estimates fall by 16%

Chief Executive Officer recently bought kr133k worth of stock

Chief Executive Officer recently bought kr133k worth of stock

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ), Annual General Meeting, Jun 02, 2022

Insufficient new directors

OssDsign AB (publ.) Receives Approval to Establish Clinical Registry in the U.S. to Collect Real-World Data on OssDsign Catalyst

Forecast to breakeven in 2024

OssDesign AB (Publ.) Announces Updated Clinical Data from A Long-Term Follow-Up of the Company's Innovative Product OssDsign Cranial PSI, Which Is Used in the Treatment of Cranial Bone Defects

Chief Executive Officer recently bought kr124k worth of stock

Third quarter 2021 earnings released: kr0.30 loss per share (vs kr1.10 loss in 3Q 2020)

Second quarter 2021 earnings released: kr0.40 loss per share (vs kr1.30 loss in 2Q 2020)

Independent Chairman of the Board recently bought kr150k worth of stock

Consensus EPS estimates increase to -kr3.00

Price target decreased to kr17.33

Chief Executive Officer recently bought kr210k worth of stock

Chief Executive Officer recently bought kr388k worth of stock

Ossdsign AB (Publ) Announces Innovative Synthetic Bone Graft Outperforms a Comparable Device in Bone Formation Following Spinal Fusion Surgery

Chief Financial Officer recently bought kr214k worth of stock

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 240.506091 million.